Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Cash & Equivalents (2020 - 2025)

Alignment Healthcare (ALHC) has disclosed Cash & Equivalents for 6 consecutive years, with $618.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents rose 81.62% year-over-year to $618.1 million, compared with a TTM value of $618.1 million through Sep 2025, up 81.62%, and an annual FY2024 reading of $432.9 million, up 113.33% over the prior year.
  • Cash & Equivalents was $618.1 million for Q3 2025 at Alignment Healthcare, up from $470.3 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $618.1 million in Q3 2025 and bottomed at $2.3 million in Q2 2021.
  • Average Cash & Equivalents over 5 years is $394.9 million, with a median of $421.2 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents surged 19202.98% in 2022, then tumbled 50.46% in 2023.
  • Year by year, Cash & Equivalents stood at $466.6 million in 2021, then dropped by 12.23% to $409.5 million in 2022, then crashed by 50.46% to $202.9 million in 2023, then surged by 113.33% to $432.9 million in 2024, then surged by 42.79% to $618.1 million in 2025.
  • Business Quant data shows Cash & Equivalents for ALHC at $618.1 million in Q3 2025, $470.3 million in Q2 2025, and $446.2 million in Q1 2025.